Contraceptive prevalence, any modern method in Uzbekistan
Uzbekistan: Contraceptive prevalence, any modern method was 56.4% in 2022. ▬ Flat
Contraceptive prevalence, any modern method in Uzbekistan, 1996–2022
Source: Household surveys, United Nations (UN), note: Household surveys, including Demographic and Health Surveys and Multiple Indicator Cluster Surveys. Largely compiled by United Nations Population Division. Measured in % of married women ages 15-49.
Analysis
In 2022, contraceptive prevalence, any modern method in Uzbekistan stood at 56.4%.
Over the whole period, contraceptive prevalence, any modern method in Uzbekistan peaked at 63.6% in 2000 and was at its lowest, 51.3%, in 1996.
Uzbekistan ranks 36th of 113 countries on this measure, in the middle of the range.
Contraceptive prevalence, any modern method in Uzbekistan, year by year
| Year | % of married women ages 15-49 | Change |
|---|---|---|
| 1996 | 51.3% | — |
| 2000 | 63.6% | +24.0% |
| 2002 | 62.8% | -1.3% |
| 2006 | 61.7% | -1.8% |
| 2022 | 56.4% | -8.6% |
Uzbekistan compared with similar countries
- Uzbekistan's 56.4% is above the median for lower middle income countries, which is 45.1%, 1.3× the median. (37 countries reporting)
- Uzbekistan's 56.4% is above the median for Europe & Central Asia, which is 52.4%, 1.1× the median. (24 countries reporting)
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 1990s | 51.3% | 51.3% | 51.3% | 1 |
| 2000s | 62.7% | 61.7% | 63.6% | 3 |
| 2020s | 56.4% | 56.4% | 56.4% | 1 |
Countries ranked near Uzbekistan
More health data for Uzbekistan
- Un projection of annual infant deaths, annual growth rate -1.21 % change on previous year (2100)
- Heat deaths vs projected death rates, annual growth rate 0.2049 % change on previous year (2090)
- Estimated changes in temperature-related death rates compared to projected death rates 782.5 deaths per 1,000 people (2090)
- Number of infants who die before age 1 3,269 deaths (2100)
- Neonatal tetanus - number of reported cases, gaps filled 0 (2024)
- Population ages 00-04, female, annual growth rate 1.88 % change on previous year (2025)
- Population ages 00-04, female, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 00-04, female, per capita 0.0589 units per person (2025)
- Population ages 00-04, male, annual growth rate 1.77 % change on previous year (2025)
- Population ages 00-04, male, per unit of GDP 0 units per US$ of GDP (2025)
Frequently asked questions
- What is contraceptive prevalence, any modern method in Uzbekistan?
- Contraceptive prevalence, any modern method in Uzbekistan was 56.4% in 2022, according to Household surveys, United Nations (UN), note: Household surveys, including Demographic and Health Surveys and Multiple Indicator Cluster Surveys. Largely compiled by United Nations Population Division.
- What is the highest contraceptive prevalence, any modern method recorded in Uzbekistan?
- The highest recorded value was 63.6% in 2000.
- What is the lowest contraceptive prevalence, any modern method recorded in Uzbekistan?
- The lowest recorded value was 51.3% in 1996.
- How does Uzbekistan rank for contraceptive prevalence, any modern method?
- Uzbekistan ranks 36th out of 113 countries with data for 2022.
- Where does this Uzbekistan data come from?
- The figures come from Household surveys, United Nations (UN), note: Household surveys, including Demographic and Health Surveys and Multiple Indicator Cluster Surveys. Largely compiled by United Nations Population Division, published as part of Contraceptive prevalence, any modern method (% of married women ages 15-49). Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 5 observations, free to reuse under CC BY 4.0 (World Bank Open Data).
About this data
Contraceptive prevalence, any modern method is the percentage of married women ages 15-49 who are practicing, or whose sexual partners are practicing, at least one modern method of contraception. Modern methods of contraception include female and male sterilization, oral hormonal pills, the intra-uterine device (IUD), the male condom, injectables, the implant (including Norplant), vaginal barrier methods, the female condom and emergency contraception.